CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
From Hematologic Oncology Update by Dr. Neil Love
March 23, 2026 · 24 min · Season 25 · Episode 72
About this episode
Dr. Paul G Richardson discusses CELMoDs and their role in treating multiple myeloma.
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma. CME information and select publications here .
People in this episode
Host: Dr. Neil Love
Guest: Dr Paul G Richardson
Topics covered
- CELMoDs
- Multiple Myeloma
- Cancer Treatment
- Hematologic Oncology
- Microlearning
Keywords
- CELMoDs
- Multiple Myeloma
- Cancer Treatment
- Hematologic Oncology
- CME
Mentioned in this episode
Organizations: Dana-Farber Cancer Institute
Places: Boston, Massachusetts
More episodes of Hematologic Oncology Update
- Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances · May 23, 2026 · 59 min
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances · April 20, 2026 · 59 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson · April 10, 2026 · 25 min
- Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review · April 1, 2026 · 25 min
- Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review · March 21, 2026 · 29 min
- CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah · March 13, 2026 · 1h 3m
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.